...

首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >IMPROVE-IT Trial: A Comparison of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Cardiovascular Outcomes After Acute Coronary Syndromes

【24h】

IMPROVE-IT Trial: A Comparison of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Cardiovascular Outcomes After Acute Coronary Syndromes

机译：IMPROVE-IT试验：依泽替米贝/辛伐他汀与辛伐他汀单药治疗急性冠状动脉综合征后心血管结果的比较

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Circulation: An Official Journal of the American Heart Association》 |2014年第23期|共1页
作者
Cannon Christopher P.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词
Cholesterol; Cholesterol-lowering drugs; Clinical trials; Prevention; Acute coronary syndromes;

机译：胆固醇;降胆固醇药;临床试验;预防;急性冠脉综合征;

相似文献

外文文献
中文文献
专利

1. IMPROVE-IT Trial: A Comparison of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Cardiovascular Outcomes After Acute Coronary Syndromes [J] . Cannon Christopher P. Circulation: An Official Journal of the American Heart Association . 2014,第23期

机译：IMPROVE-IT试验：依泽替米贝/辛伐他汀与辛伐他汀单药治疗急性冠状动脉综合征后心血管结果的比较
2. Cost-Effectiveness of Simvastatin Plus Ezetimibe for Cardiovascular Prevention in Patients With a History of Acute Coronary Syndrome: Analysis of Results of the IMPROVE-IT Trial [J] . Almalki Ziyad S., Guo Jeff Jianfei, Alahmari Abdullah, Heart, lung & circulation . 2018,第6期

机译：辛伐他汀加欧塞蒂米贝对急性冠状动脉综合征史上心血管预防的成本效益：改善IT试验结果分析
3. Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome The IMPROVE-IT Trial [J] . Murphy Sabina A., Cannon Christopher P., Blazing Michael A., Journal of the American College of Cardiology . 2016,第4期

机译：Ezetimibe / Simvastatin急性冠脉综合征后总心血管事件的减少IMPROVE-IT试验
4. Antidepressant prevention of depression and cardiovascular sequelae post-acute coronary syndrome: The "AVERT' trial [C] . Louis T. van Zyl, Hoshiar Abdollah, Kevin Parke World Congress on Psychosomatic Medicine . 2006

机译：抑郁症和心血管后遗症后急性冠状动脉综合征的抗抑郁药预防：“避免”试验
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter randomized trial (the LEAD study) [O] . Gianluca Bardini, Carlo B Giorda, Antonio E Pontiroli, 2010

机译：依泽替米贝+辛伐他汀与辛伐他汀剂量加倍与高心血管风险糖尿病患者的关系：一项多中心随机试验（LEAD研究）
7. Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome The IMPROVE-IT Trial [O] . Murphy Sabina A., Cannon Christopher P., Blazing Michael A., 2016

机译：Ezetimibe / Simvastatin急性冠状动脉综合征后总心血管事件的减少IMPROVE-IT试验

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号